Inflammation Control For Elders: ICE Study

NCT02079948 ↗

Phase 2 Withdrawn University of Florida National Institute on Aging (NIA) · collab

RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study will be the first to test whether a selected anti-inflammatory agent, methotrexate, reduces inflammation in a human body, improve cognitive and physical function, and reduce pain levels in older adults at risk for functional decline, due to systemic inflammation.

Timeline

Start: 2014-02
Primary completion: 2014-09
Completion: 2014-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Methotrexate	Small molecule	15 mg	Oral
Background	folic acid	Other / unclassified	1 mg	Oral

Indications

No indication recorded.